Department of Pediatrics.
Department of Cell Biology and Physiology.
JCI Insight. 2023 Jun 8;8(11):e168836. doi: 10.1172/jci.insight.168836.
DNAAF5 is a dynein motor assembly factor associated with the autosomal heterogenic recessive condition of motile cilia, primary ciliary dyskinesia (PCD). The effects of allele heterozygosity on motile cilia function are unknown. We used CRISPR-Cas9 genome editing in mice to recreate a human missense variant identified in patients with mild PCD and a second, frameshift-null deletion in Dnaaf5. Litters with Dnaaf5 heteroallelic variants showed distinct missense and null gene dosage effects. Homozygosity for the null Dnaaf5 alleles was embryonic lethal. Compound heterozygous animals with the missense and null alleles showed severe disease manifesting as hydrocephalus and early lethality. However, animals homozygous for the missense mutation had improved survival, with partially preserved cilia function and motor assembly observed by ultrastructure analysis. Notably, the same variant alleles exhibited divergent cilia function across different multiciliated tissues. Proteomic analysis of isolated airway cilia from mutant mice revealed reduction in some axonemal regulatory and structural proteins not previously reported in DNAAF5 variants. Transcriptional analysis of mouse and human mutant cells showed increased expression of genes coding for axonemal proteins. These findings suggest allele-specific and tissue-specific molecular requirements for cilia motor assembly that may affect disease phenotypes and clinical trajectory in motile ciliopathies.
DNAAF5 是一种与常染色体异质性隐性运动纤毛疾病、原发性纤毛运动障碍(PCD)相关的动力蛋白装配因子。等位基因杂合性对运动纤毛功能的影响尚不清楚。我们使用 CRISPR-Cas9 基因组编辑在小鼠中重现了在轻度 PCD 患者中发现的人类错义变异体,以及 Dnaaf5 的第二个移码缺失。具有 Dnaaf5 异型等位基因的后代显示出明显的错义和纯合基因剂量效应。纯合子缺失 Dnaaf5 等位基因的胚胎致死。具有错义和缺失等位基因的复合杂合子动物表现出严重的疾病,表现为脑积水和早期致死。然而,具有错义突变的纯合子动物具有更好的生存能力,超微结构分析显示部分保留了纤毛功能和运动装配。值得注意的是,相同的变体等位基因在不同的多纤毛组织中表现出不同的纤毛功能。从突变小鼠分离的气道纤毛的蛋白质组分析显示,一些以前未在 DNAAF5 变体中报道的轴丝调节和结构蛋白减少。对突变细胞的小鼠和人类的转录组分析显示,编码轴丝蛋白的基因表达增加。这些发现表明纤毛运动装配的等位基因特异性和组织特异性分子要求,可能影响运动纤毛疾病的表型和临床轨迹。